Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma

NCT04749108 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

1075

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Malignant Neoplasm
Rectal Carcinoma

Interventions

DRUG: Induction chemotherapy - modified FOLFIRINOX regimen
OTHER: Early tumor response evaluation by MRI volumetry
RADIATION: Radiochemotherapy Cap 50
PROCEDURE: Radical proctectomy with total mesorectal excision

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle